Cardiology Search
Cardiology Cardiology
hypertension
HYPERTENSION
Hypertension is the medical term for high blood pressure. Persistent high blood pressure can lead to increased strain to the heart and arteries that can eventually cause organ damage.
To classify the blood pressure, it must be based on ≥2 properly measured, seated blood pressure readings on each of ≥2 office visits.
Goals of therapy are to manage hypertension that can maintain the patient's normal blood pressure and identify and treat all reversible risk factors.

Introduction


  • Hypertension is the medical term for high blood pressure
  • Symptoms may come from secondary causes, concomitant diseases, or from target organ damage (TOD)
  • Assessment with lab tests and imaging may be done to exclude secondary causes, additional cardiovascular risk factors, or TOD
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Slideshow: Highlights from the American Heart Association (AHA) Scientific Sessions 2019
28 Nov 2019
Slideshow: Highlights from the American Heart Association (AHA) Scientific Sessions 2019
High trunk fat mass may increase CVD risk in postmenopausal women regardless of BMI
Elaine Soliven, 27 Nov 2019
High levels of trunk fat mass (FM) may be associated with an increased risk of cardiovascular disease (CVD)-related events such as coronary death, nonfatal myocardial infarction, or coronary heart disease in postmenopausal women with normal body mass index (BMI), according to a recent study presented at AHA 2019.
CRP-to-albumin ratio predicts acute kidney injury in STEMI patients
28 Oct 2019
The C-reactive protein (CRP)-to-albumin ratio (CAR) appears to be linked to the development of acute kidney injury in patients with ST elevation myocardial infarction (STEMI), a recent study has found.
Evolocumab added to high-intensity statins safely lowers LDL-C levels in acute ACS patients
28 Nov 2019
The addition of evolocumab to high-intensity statin therapy is both well tolerated and effective in significantly reducing low-density lipoprotein cholesterol (LDL-C) levels in patients hospitalized for acute coronary syndromes (ACS), allowing most of them to achieve current recommended target levels, a study has shown.